Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 3
1988 1
1989 1
1990 6
1991 2
1992 2
1993 2
1994 3
1995 1
1998 1
1999 2
2001 3
2002 2
2003 6
2004 2
2005 4
2006 2
2007 4
2008 5
2009 5
2010 9
2011 6
2012 6
2013 6
2014 3
2015 5
2016 6
2017 8
2018 3
2019 10
2020 12
2021 19
2022 8
Text availability
Article attribute
Article type
Publication date

Search Results

151 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial.
Udwadia ZF, Singh P, Barkate H, Patil S, Rangwala S, Pendse A, Kadam J, Wu W, Caracta CF, Tandon M. Udwadia ZF, et al. Int J Infect Dis. 2021 Feb;103:62-71. doi: 10.1016/j.ijid.2020.11.142. Epub 2020 Nov 16. Int J Infect Dis. 2021. PMID: 33212256 Free PMC article. Clinical Trial.
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017, Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Bonnet M, Brode SK, Brust JCM, Cai Y, Caumes E, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Cirule A, Dalcolmo MP, D'Ambrosio L, de Vries G, Dheda K, Esmail A, Flood J, Fox GJ, Fréchet-Jachym M, Fregona G, Gayoso R, Gegia M, Gler MT, Gu S, Guglielmetti L, Holtz TH, Hughes J, Isaakidis P, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Laniado-Laborín R, Lee M, Leimane V, Leung CC, Leung EC, Li PZ, Lowenthal P, Maciel EL, Marks SM, Mase S, Mbuagbaw L, Migliori GB, Milanov V, Miller AC, Mitnick CD, Modongo C, Mohr E, Monedero I, Nahid P, Ndjeka N, O'Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Robert J, Rodriguez M, Seaworth B, Seung KJ, Schnippel K, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu L, Udwadia ZF, van der Werf TS, Veziris N, Viiklepp P, Vilbrun SC, Walsh K, Westenhouse J, Yew WW, Yim JJ, Zetola NM, Zignol M, Menzies D. Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017, et al. Among authors: udwadia zf. Lancet. 2018 Sep 8;392(10150):821-834. doi: 10.1016/S0140-6736(18)31644-1. Lancet. 2018. PMID: 30215381 Free PMC article. Review.
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Lan Z, Ahmad N, Baghaei P, Barkane L, Benedetti A, Brode SK, Brust JCM, Campbell JR, Chang VWL, Falzon D, Guglielmetti L, Isaakidis P, Kempker RR, Kipiani M, Kuksa L, Lange C, Laniado-Laborín R, Nahid P, Rodrigues D, Singla R, Udwadia ZF, Menzies D; Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment 2017. Lan Z, et al. Among authors: udwadia zf. Lancet Respir Med. 2020 Apr;8(4):383-394. doi: 10.1016/S2213-2600(20)30047-3. Epub 2020 Mar 17. Lancet Respir Med. 2020. PMID: 32192585 Free PMC article.
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.
Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, Furin J, Nardell EA, London L, Lessem E, Theron G, van Helden P, Niemann S, Merker M, Dowdy D, Van Rie A, Siu GK, Pasipanodya JG, Rodrigues C, Clark TG, Sirgel FA, Esmail A, Lin HH, Atre SR, Schaaf HS, Chang KC, Lange C, Nahid P, Udwadia ZF, Horsburgh CR Jr, Churchyard GJ, Menzies D, Hesseling AC, Nuermberger E, McIlleron H, Fennelly KP, Goemaere E, Jaramillo E, Low M, Jara CM, Padayatchi N, Warren RM. Dheda K, et al. Among authors: udwadia zf. Lancet Respir Med. 2017 Mar 15:S2213-2600(17)30079-6. doi: 10.1016/S2213-2600(17)30079-6. Online ahead of print. Lancet Respir Med. 2017. PMID: 28344011 Review.
Audio Interview: India's Covid-19 Crisis.
Rubin EJ, Baden LR, Udwadia ZF, Morrissey S. Rubin EJ, et al. Among authors: udwadia zf. N Engl J Med. 2021 May 6;384(18):e84. doi: 10.1056/NEJMe2107728. N Engl J Med. 2021. PMID: 33951370 No abstract available.
COPD Management during the COVID-19 pandemic.
Salvi SS, Dhar R, Mahesh PA, Udwadia ZF, Behra D. Salvi SS, et al. Among authors: udwadia zf. Lung India. 2021 Mar;38(Supplement):S80-S85. doi: 10.4103/lungindia.lungindia_685_20. Lung India. 2021. PMID: 33686988 Free PMC article. No abstract available.
Reply to van Deun and Decroo.
Cegielski JP, Udwadia ZF, Viiklepp P, Yim JJ, Menzies D. Cegielski JP, et al. Among authors: udwadia zf. Clin Infect Dis. 2021 Jun 15;72(12):e1168-e1169. doi: 10.1093/cid/ciaa1875. Clin Infect Dis. 2021. PMID: 33341886 No abstract available.
Asia-Pacific perspectives on the COVID-19 pandemic.
Pawankar R, Thong BY, Tiongco-Recto M, Wang JY, Abdul Latiff AH, Thien F, Oh JW, Kamchaisatian W, Rengganis I, Udwadia ZF, Dhar R, Munkhbayarlakh S, Narantsetseg L, Le Pham D, Leung TF, Zhang L; APAAACI COVID-19 Working Group. Pawankar R, et al. Among authors: udwadia zf. Allergy. 2021 Sep;76(9):2998-2901. doi: 10.1111/all.14894. Epub 2021 May 18. Allergy. 2021. PMID: 33948966 Free PMC article. No abstract available.
Tuberculosis in India.
Udwadia ZF, Mehra C. Udwadia ZF, et al. BMJ. 2015 Mar 23;350:h1080. doi: 10.1136/bmj.h1080. BMJ. 2015. PMID: 25805828 No abstract available.
151 results